During Tuesday’s Morning trade, Shares of Whiting Petroleum Corp. (NYSE:WLL), gained 2.89% to $19.60.
Whiting Petroleum declared that it has designated Carin S. Knickel to the Company’s Board of Directors. Ms. Knickel served as Vice President, Human Resources of ConocoPhillips, Inc. from 2003 until her retirement in 2012. She has 35 years of experience in the oil and gas industry startning her career with Conoco in 1979, serving in the United States and Europe in executive, operations administration, marketing, planning and business development positions. She holds a bachelor’s degree in marketing and statistics from the University of Colorado and a master’s degree in administration from Massachusetts Institute of Technology. Ms. Knickel also serves on the Board of Hudbay Minerals, Inc. (HBM) and the Engineering Advisory Council for the College of Engineering, University of Colorado.
On behalf of the Whiting Petroleum Corporation Board of Directors, James J. Volker, Chairman, President and Chief Executive Officer said, “We are very happy that Carin Knickel is joining Whiting’s Board of Directors. Carin’s depth and breadth of experience in various board member, executive and operating roles in the oil and gas industry is a great addition to Whiting’s Board.”
Whiting Petroleum Corporation, an independent oil and gas company, acquires, explores, develops, and produces crude oil, natural gas liquids, and natural gas in the Rocky Mountains and Permian Basin regions of the United States. It sells oil and gas to end users, marketers, and other purchasers.
Shares of American International Group, Inc. (NYSE:AIG), declined -2.90% to $62.29, during its current trading session.
American International Group declared the following actions taken by its Board of Directors:
- Authorized the repurchase of additional shares of AIG Common Stock with an aggregate purchase price of up to $5.0 billion. During the first half of 2015, AIG repurchased about $3.7 billion of shares of AIG Common Stock, following preceding authorizations from the Board of Directors. AIG made additional repurchases of about $965 million through the end of July 2015. AIG’s aggregate remaining share repurchase authorization, inclusive of recently’s declared $5.0 billion authorization, is about $6.3 billion. Repurchases may be made from time to time in the open market, private purchases, through forward, derivative, accelerated repurchase or automatic repurchase transactions, or otherwise.
- Declared a 124 percent enhance in the quarterly dividend to $0.28 per share on AIG Common Stock, par value $2.50 per share. The dividend is payable on September 28, 2015, to stockholders of record at the close of business on September 14, 2015.
American International Group, Inc. provides insurance products and services for commercial, institutional, and individual customers in the United States, the Asia Pacific, and internationally.
Finally, CVS Health Corporation (NYSE:CVS), lost -4.46%, and is now trading at $107.79.
CVS Health Corporation declared operating results for the three months ended June 30, 2015.
Revenues
Net revenues for the three months ended June 30, 2015, raised 7.4%, or $2.6 billion, to $37.2 billion contrast to the three months ended June 30, 2014.
Revenues in the Pharmacy Services Segment raised 11.9%, or $2.6 billion, to $24.4 billion in the three months ended June 30, 2015. The enhance was primarily driven by growth in specialty pharmacy and pharmacy network claims. Pharmacy network claims processed during the three months ended June 30, 2015, raised 8.7% to about 229 million contrast to 210 million in the preceding year. The enhance in the pharmacy network claim volume was primarily due to net new business in addition to growth in Managed Medicaid. Mail choice claims processed during the three months ended June 30, 2015, raised 3.9% to 21.3 million, contrast to 20.5 million in the preceding year. The enhance in mail choice claims was driven by specialty claim volume and raised claims associated with the continued adoption of our Maintenance Choice® offerings.
Revenues in the Retail Pharmacy Segment raised 2.2%, or $371 million, to $17.2 billion in the three months ended June 30, 2015. Same store sales raised 0.5% as compared to the second quarter of last year, with pharmacy same store sales up 4.1% and front store same store sales down 7.8%. On a comparable basis, front store same store sales would have been about 780 basis points higher if tobacco and the estimated associated basket sales were excluded from the three months ended June 30, 2014. Front store same store sales were influenced by softer customer traffic, partially offset by an enhance in basket size. Pharmacy same store prescription volumes rose 4.8% on a 30-day equivalent basis. Pharmacy same store sales were negatively influenced by about 370 basis points from recent generic drug introductions and by about 80 basis points from the implementation of Specialty Connect®. The implementation of Specialty Connect had a greater effect on revenues than prescription volumes due to the higher dollar value of specialty products.
For the three months ended June 30, 2015, the generic dispensing rate raised about 150 basis points from the preceding year in both segments, rising to 83.9% in the Pharmacy Services Segment and 85.0% in the Retail Pharmacy Segment.
CVS Health Corporation, together with its auxiliaries, provides integrated pharmacy health care services in the United States. The company operates through Pharmacy Services and Retail Pharmacy segments.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties, which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified with such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should/might occur.
